CARDIOPHARMA ApS: Financial statements 2020
CVR: 13966273
Source: annual report 2020, Danish Business Authority
01/05/2019 – 30/04/2020
CARDIOPHARMA ApS (CVR 13966273) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,396,663 and a net result of DKK 1,574,631 compared with DKK 1,728,623 the year before. That is an increase of 36.3% compared with the year before. Equity in the 2020 report amounted to DKK 26,202,077. The solvency ratio was 99.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,396,663
- Profit/Loss
- DKK 1,574,631
- Equity
- DKK 26,202,077
- Total Assets
- DKK 26,247,810
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.4 mio. | 1.6 mio. | 26.2 mio. | 1 |
| 2019 | - | 1.8 mio. | 1.7 mio. | 25 mio. | 1 |
| 2018 | - | 35 t. | 1.1 mio. | 24.3 mio. | - |
| 2017 | - | 947 t. | 2.5 mio. | 23.2 mio. | - |
| 2016 | - | 4.5 mio. | 2.2 mio. | 21.4 mio. | - |
Official annual report
How creditworthy is CARDIOPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout CARDIOPHARMA ApS
CARDIOPHARMA ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 1990. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named KM 455 ApS. The management consists of Niels Christian Fischer Petersen. The company is owned by Niels Christian Fischer Petersen. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 4,336,132 and a net result of DKK 3,090,043 compared with DKK 1,968,388 the year before. Equity in the 2026 report amounted to DKK 31,593,726.